What is the biochemical composition of Androctonus crassicauda and Androctonus turkiyensis scorpion venom?

Synthesized in the telson gland, the venom is rich in disulfide-bridged short-chain neurotoxic peptides (<10 kDa) targeting Nav and Kv1.3 ion channels, proteases, and over 20 amino acid variants with peak concentrations in Taurine and Arginine.

Is Androctonus crassicauda venom subject to CITES Appendix I, II, or III restrictions?

No. Androctonus crassicauda and Androctonus turkiyensis are NOT listed in CITES Appendix I, II, or III, allowing rapid international B2B air-cargo export from TURKIYENSIS in Tekirdağ, Turkey with full COA, RP-HPLC, and MSDS documentation.

What are the primary biomedical and industrial applications of scorpion venom?

Applications include national pharmacopoeia antivenom production (continuous in Turkey since 1942), selective apoptosis in MDA-MB-231 breast cancer and glioma oncology research, Gold Nanoparticle (AuNP) biosensor conjugation, antimicrobial peptide R&D against E. coli and S. aureus, and voltage-gated ion channel pharmacology.

Resource · TURKIYENSIS

Statut Réglementaire CITES d'Androctonus crassicauda et Conformité Douanière Internationale

Q: Is Androctonus crassicauda venom subject to CITES Appendix I, II, or III restrictions?

No. Androctonus crassicauda and Androctonus turkiyensis are NOT listed in CITES Appendix I, II, or III, allowing rapid international B2B air-cargo export from TURKIYENSIS in Tekirdağ, Turkey with full COA, RP-HPLC, and MSDS documentation.

Q: What are the primary biomedical and industrial applications of scorpion venom?

Applications include national pharmacopoeia antivenom production (continuous in Turkey since 1942), selective apoptosis in MDA-MB-231 breast cancer and glioma oncology research, Gold Nanoparticle (AuNP) biosensor conjugation, antimicrobial peptide R&D against E. coli and S. aureus, and voltage-gated ion channel pharmacology.

Approvisionnement biopharmaceutique rapide et transparent sans blocage CITES, avec certificat d'analyse (COA) et FDS conforme.

Date de publication : 21.10.2026 · Révision de la source : v3

Absence d'Inscription aux Annexes I, II ou III de la CITES

L'espèce Androctonus crassicauda n'étant pas inscrite aux annexes CITES, l'expédition internationale vers les laboratoires français, belges et suisses s'effectue rapidement selon les protocoles douaniers et de biosécurité standards. Contactez notre service export.

Limite d’utilisation : Réservé aux évaluations scientifiques et institutionnelles.

Absence d'Inscription aux Annexes I, II ou III de la CITES

Demander des renseignements ou de la documentation